When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Progyny just met that criteria with a new score of 84.
This unique rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against the rest of the market.
Over 100 years of market history shows that the best-performing stocks typically have an RS Rating north of 80 in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to form a consolidation and break out.
The company reported 5% EPS growth in its most recent report. Sales gains came in at 2%. The next quarterly results are expected on or around Feb. 27.
Progyny holds the No. 6 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Option Care Health and Progyny are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
